These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8516792)

  • 1. The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction.
    Dzik WH; Jones KS
    Transfusion; 1993 Jun; 33(6):493-6. PubMed ID: 8516792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma radiation.
    Rosen NR; Weidner JG; Boldt HD; Rosen DS
    Transfusion; 1993 Feb; 33(2):125-7. PubMed ID: 8430450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Castro G; Merkel PA; Giclas HE; Gibula A; Andersen GE; Corash LM; Lin JS; Green J; Knight V; Stassinopoulos A
    Transfusion; 2018 Jun; 58(6):1506-1515. PubMed ID: 29607502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment.
    Grass JA; Wafa T; Reames A; Wages D; Corash L; Ferrara JL; Lin L
    Blood; 1999 May; 93(9):3140-7. PubMed ID: 10216113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?
    Li M; Irsch J; Corash L; Benjamin RJ
    Transfus Apher Sci; 2022 Apr; 61(2):103404. PubMed ID: 35288055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone?
    Rodriguez JV; Tormey CA
    Transfus Apher Sci; 2022 Apr; 61(2):103402. PubMed ID: 35288056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemical inactivation of lymphocytes by riboflavin with visible light for TA-GVHD prevention.
    Mo Q; Huang Y; Wang L; Cheng Z; Wu X; Jia Y; Wang X; Zhang B
    J Photochem Photobiol B; 2017 Sep; 174():276-283. PubMed ID: 28806684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion of pathogen-reduced platelet components without leukoreduction.
    Sim J; Tsoi WC; Lee CK; Leung R; Lam CCK; Koontz C; Liu AY; Huang N; Benjamin RJ; Vermeij HJ; Stassinopoulos A; Corash L; Lie AKW
    Transfusion; 2019 Jun; 59(6):1953-1961. PubMed ID: 30919465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters.
    Akahoshi M; Takanashi M; Masuda M; Yamashita H; Hidano A; Hasegawa K; Kasajima T; Shimizu M; Motoji T; Oshimi K
    Transfusion; 1992 Feb; 32(2):169-72. PubMed ID: 1542924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated graft-versus-host disease: current concepts and future trends.
    Seghatchian MJ; Ala F
    Transfus Sci; 1995 Jun; 16(2):99-105. PubMed ID: 10155741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-irradiation and gamma-irradiation inactivate lymphocytes in blood components.
    Davis AM; Aung HH; Costa MJ; Dennington PM; van der Wal DE; Marks DC
    Transfusion; 2021 Nov; 61(11):3081-3086. PubMed ID: 34554562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood.
    Chang H; Voralia M; Bali M; Sher GD; Branch DR
    Br J Haematol; 2000 Oct; 111(1):146-56. PubMed ID: 11091195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray].
    Tanaka S
    Nihon Rinsho; 1997 Sep; 55(9):2277-81. PubMed ID: 9301290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease.
    Pelszynski MM; Moroff G; Luban NL; Taylor BJ; Quinones RR
    Blood; 1994 Mar; 83(6):1683-9. PubMed ID: 8123860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice.
    Stark J; Weiss L; Slavin S
    Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-filtered leukoreduction as a method for risk reduction of transfusion-associated graft-versus-host disease.
    Chun S; Phan MT; Hong S; Yang J; Yoon Y; Han S; Kang J; Yazer MH; Kim J; Cho D
    PLoS One; 2020; 15(3):e0229724. PubMed ID: 32214402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in the prevention of transfusion-associated graft-versus-host disease.
    Fast LD
    Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.